256 related articles for article (PubMed ID: 33956965)
1. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
[TBL] [Abstract][Full Text] [Related]
2. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
4. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
5. Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation.
Akhmedov M; Klyasova G; Kuzmina L; Fedorova A; Drokov M; Parovichnikova E
Leuk Lymphoma; 2023 Jun; 64(6):1102-1111. PubMed ID: 37086466
[TBL] [Abstract][Full Text] [Related]
6. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
[TBL] [Abstract][Full Text] [Related]
9. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
[TBL] [Abstract][Full Text] [Related]
11. Comparison between Perianal Swab and Stool Specimens for Detecting Colonization with Extended-Spectrum Beta-Lactamase-Producing and Fluoroquinolone-Resistant
Kubiak JM; Hovan M; Davidson E; Douglass C; Burgos K; Walsh TJ; Westblade LF; Satlin MJ
J Clin Microbiol; 2022 Jul; 60(7):e0023422. PubMed ID: 35695506
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
Hakki M; Humphries RM; Hemarajata P; Tallman GB; Shields RK; Mettus RT; Doi Y; Lewis JS
Clin Infect Dis; 2019 May; 68(12):2045-2052. PubMed ID: 30256922
[TBL] [Abstract][Full Text] [Related]
13. Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria.
Stoma I; Littmann ER; Peled JU; Giralt S; van den Brink MRM; Pamer EG; Taur Y
Clin Infect Dis; 2021 Dec; 73(11):e4627-e4635. PubMed ID: 31976518
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Simondsen KA; Reed MP; Mably MS; Zhang Y; Longo WL
J Oncol Pharm Pract; 2013 Dec; 19(4):291-7. PubMed ID: 23184539
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
Rambaran KA; Seifert CF
J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Copeland V; McLaughlin M; Trifilio S
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
[TBL] [Abstract][Full Text] [Related]
18. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients.
Gottesdiener LS; Satlin MJ
Transpl Infect Dis; 2023 Nov; 25 Suppl 1(Suppl 1):e14169. PubMed ID: 37864309
[TBL] [Abstract][Full Text] [Related]
19. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
